Akari Therapeutics, Plc - SIC # 2830 -

Ticker Exchange SIC # Website Latest Ticker
AKTX Nasdaq 2830 www.akaritx.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Akari Therapeutics, Plc

European Equities Traded in the US as American Depositary Receipts Decline in Thursday Trading - Feb 12th, 2026 9:21 am
European Equities Traded in the US as American Depositary Receipts Slightly Higher in Wednesday Trading - Feb 11th, 2026 9:05 am
Akari Therapeutics Participates in Virtual Investor “What This Means” Interview Discussing the Company’s Expanded ADC Pipeline - Feb 11th, 2026 6:45 am
JTC Team Companies to Present in Webull Corporate Connect Webinar Series Happening February 10-11, 2026 - Feb 9th, 2026 9:30 am
European Equities Traded in the US as American Depositary Receipts Rise in Monday Trading - Feb 9th, 2026 9:12 am
European Equities Traded in the US as American Depositary Receipts Fall Sharply in Thursday Trading - Feb 5th, 2026 9:14 am
Akari Therapeutics to Participate in the Corporate Connect Webinar Series Virtual Conference Hosted by Webull Financial - Feb 5th, 2026 7:15 am
European Equities Traded in the US as American Depositary Receipts Edge Lower in Friday Trading; Up for Week - Jan 30th, 2026 9:14 am
Akari Therapeutics Files Key Patent and Unveils Second ADC Program AKTX-102 Targeting CEACAM5 Expressing Solid Tumors - Jan 26th, 2026 6:45 am
European Equities Traded in the US as American Depositary Receipts Rise in Friday Trading; Up 1.4% for Week - Jan 23rd, 2026 9:06 am
MarketBeat Week in Review – 01/12 - 01/16 - Jan 17th, 2026 5:00 am
European Equities Traded in the US as American Depositary Receipts Rise Slightly in Tuesday Trading - Jan 13th, 2026 9:10 am
European Equities Traded in the US as American Depositary Receipts Rise in Friday Trading - Jan 9th, 2026 9:14 am
Akari Therapeutics Releases New CEO Corner Segment Highlighting 2025 Progress and Path to Clinical Transition In 2026 - Jan 9th, 2026 7:00 am
Akari Therapeutics to Present at the 2026 Biotech Showcase - Jan 8th, 2026 7:15 am
Akari Therapeutics Issues 2025 End of Year Letter to Shareholders - Dec 30th, 2025 7:15 am
European Equities Traded in the US as American Depositary Receipts Rise in Wednesday Trading - Dec 24th, 2025 9:14 am
Akari Therapeutics Initiates GMP Manufacturing of AKTX-101 ADC Program to Support Phase 1 First-in-Human Clinical Trial - Dec 23rd, 2025 6:30 am
Insiders Who Purchased US$1.81m Of Akari Therapeutics Stock May Not Have Expected 36% Tumble - Dec 23rd, 2025 3:43 am
European Equities Traded in the US as American Depositary Receipts Track Higher in Thursday Trading - Dec 18th, 2025 9:05 am